Key Takeaways
- Cerebras announces second-quarter financial results Wednesday after market close; Wall Street projects core revenue reaching $191 million, representing an 84% jump from last year
- Analysts anticipate an adjusted per-share loss of $0.17; profitability not anticipated until 2026
- Shares of CBRS have declined over 25% since the start of the year, fluctuating in a range of $162 to $244 following its May market debut
- Derivatives traders suggest potential for an 11% upward move through week’s end, evidenced by a 0.56x put-to-call ratio on August 14 expiration contracts
- Wall Street maintains a “Strong Buy” consensus with average target price of $282, indicating potential gains exceeding 20%
Cerebras Systems is scheduled to unveil its second-quarter financial performance Wednesday following the closing bell, potentially setting the stage for significant price movement in CBRS stock on Thursday.
The company’s initial public offering occurred in May with shares priced at $185. Trading commenced at $350 with a rapid climb to $386, followed by a sharp reversal that brought shares down to $161 by late June. The stock has since traded within a $162 to $244 corridor.
CBRS shares have experienced daily fluctuations exceeding 3% on 42 occasions across its 61 trading sessionsāan unusually high volatility level for any equity.
As the earnings release approaches, shares remain down over 25% on a year-to-date basis.
Wall Street consensus calls for core revenue of $191 million. This figure would represent essentially flat sequential performance but an 84% increase compared to the comparable quarter last year.
Cerebras employs a unique revenue calculation methodology. The company excludes pass-through revenue that generates no margin while adding back warrant amortization expenses. In the previous quarter, this adjustment transformed reported sales of $193.4 million into a core revenue figure of $191.3 million.
Regarding profitability, analysts project an adjusted operating loss of $62 million alongside an adjusted per-share loss of $0.17. An alternative estimate places the consensus loss at $0.21 per share, representing a slight improvement from the $0.22 loss registered in the first quarter.
The company isn’t expected to achieve profitability until the following year.
Options Activity Signals Bullish Sentiment
Derivatives traders appear to be positioning for positive results ahead of the announcement. The put-to-call ratio for CBRS options contracts expiring August 14 stands at 0.56x, indicating stronger demand for calls relative to puts.
Maximum strike prices on these contracts reach slightly above $255. Should the bullish scenario materialize, this would translate to an 11% appreciation by week’s conclusion.
Technical indicators show the stock recently surpassed its primary moving averages, while the Relative Strength Index hovering in the mid-50s suggests accumulating momentum on the buy side.
Nevertheless, a measured approach remains prudent. CBRS currently trades at a price-to-sales ratio exceeding 80x despite the absence of profitability. Additionally, company insiders haven’t executed any purchase transactions over the trailing 12 months.
Understanding Cerebras’ Business Model
Cerebras manufactures the Wafer-Scale Engine (WSE), a processor spanning an entire 300mm silicon wafer. By integrating computing resources and memory onto a single silicon substrate, the design eliminates a critical performance constraint in AI server architecture.
This technological approach proves particularly effective for inference operations, which are experiencing rapid expansion as AI agents gain widespread adoption.
The company maintains a $25 billion order backlog, predominantly stemming from a multi-year agreement with OpenAI to provide cloud-based Cerebras server access. OpenAI additionally possesses rights to extend this arrangement.
Cerebras has secured additional partnerships with Amazon and AMD, deploying WSE processors in conjunction with their infrastructure for accelerated inference applications. The Amazon agreement includes equity warrants as compensation.
Analyst consensus maintains a “Strong Buy” rating on CBRS shares. The average target price of $282 suggests upside potential exceeding 20% from present trading levels.





